This discordance is seen also in Singapore, Japan and Korea, where the ratio of incidence to mortality is approximately 0.2 [2] and has largely been attributed to over-diagnosis of clinically insignificant prostate cancers as a result of widespread prostate-specific antigen (PSA) testing. Here, KLK3 is linked to prostate cancer.